US2005239897A1PendingUtilityA1

Mesenchymal stem cells and uses therefor

62
Assignee: PITTENGER MARK FPriority: Mar 22, 2004Filed: Mar 15, 2005Published: Oct 27, 2005
Est. expiryMar 22, 2024(expired)· nominal 20-yr term from priority
A61P 7/06A61P 37/06A61P 5/14A61P 3/10A61P 37/02A61P 7/04A61P 35/00A61P 43/00A61P 37/08A61P 37/00A61P 9/00A61P 27/02A61P 29/00A61P 25/00C12N 5/0662C12N 5/0668A61K 38/2026C12N 5/0664C12N 5/0665A61P 19/08A61P 17/00A61K 38/2066A61P 19/02A61P 17/14A61K 35/28C12N 5/0666A61P 17/02A61P 17/06C12N 5/0663A61K 2035/124A61P 13/08A61P 1/00C12N 5/0667A61P 1/04A61P 11/00A61K 45/06A61P 1/02A61K 35/12Y02A50/30
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting would healing, and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.

Claims

exact text as granted — not AI-modified
1 . A method of promoting angiogenesis in an organ or tissue of an animal other than the heart, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to promote angiogenesis in an organ or tissue other than the heart of said animal.    
     
     
         2 . The method of  claim 1  wherein said animal is a mammal.  
     
     
         3 . The method of  claim 2  wherein said mammal is a primate.  
     
     
         4 . The method of  claim 3  wherein said primate is a human.  
     
     
         5 . The method of  claim 1  wherein said mesenchymal stem cells are administered in an amount of from about 1×10 5  cells/kg to about 1×10 7  cells/kg.  
     
     
         6 . The method of  claim 5  wherein said mesenchymal stem cells are administered in an amount of from about 1×10 6  cells/kg to about 5×10 6  cells/kg.  
     
     
         7 . The method of  claim 1  wherein said mesenchymal stem cells are administered systemically.  
     
     
         8 . The method of  claim 1  wherein said mesenchymal stem cells are administered intravenously.  
     
     
         9 . The method of  claim 1  wherein said mesenchymal stem cells are administered by direct injection to said organ or tissue other than the heart of said animal.  
     
     
         10 . A method of treating an autoimmune disease in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to treat said autoimmune disease in said animal    
     
     
         11 . The method of  claim 10  wherein said animal is a mammal  
     
     
         12 . The method of  claim 11  wherein said mammal is a human.  
     
     
         13 . The method of  claim 10  wherein said autoimmune disease is multiple sclerosis.  
     
     
         14 . A method of treating an inflammatory response in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to treat said inflammatory response in said animal.    
     
     
         15 . The method of  claim 14  wherein said animal is a mammal.  
     
     
         16 . The method of  claim 15  wherein said mammal is a human.  
     
     
         17 . The method of  claim 14  wherein said inflammatory response is associated with psoriasis.  
     
     
         18 . A method of treating cancer in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to treat cancer in said animal.    
     
     
         19 . The method of  claim 18  wherein said animal is a mammal.  
     
     
         20 . The method of  claim 19  wherein said mammal is a human.  
     
     
         21 . A method of treating an allergic disease or disorder in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to treat said allergic disease or disorder in said animal.    
     
     
         22 . The method of  claim 21  wherein said animal is a mammal.  
     
     
         23 . The method of  claim 22  wherein said mammal is a human.  
     
     
         24 . The method of  claim 14  wherein said allergic disease or disorder is arthritis.  
     
     
         25 . A method of promoting wound healing in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to promote wound healing in said animal.    
     
     
         26 . The method of  claim 25  wherein said animal is a mammal.  
     
     
         27 . The method of  claim 26  wherein said mammal is a human.  
     
     
         28 . A method of preventing fibrosis in an animal, comprising: 
 administering to said animal mesenchymal stem cells in an amount effective to prevent fibrosis in said animal.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.